Cargando…

Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM

Background: Tigecycline, a glycylcycline antibiotic, is increasingly used clinically for the treatment of severe infections caused by multidrug-resistant bacteria, but it is also associated with hepatotoxicity. However, the incidence and risk factors of tigecycline-associated drug-induced liver inju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Xiaoping, Zuo, Chengchun, Yu, Lingling, Lao, Donghui, Li, Xiaoyu, Xu, Qing, Lv, Qianzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594628/ https://www.ncbi.nlm.nih.gov/pubmed/34795591 http://dx.doi.org/10.3389/fphar.2021.761167

Ejemplares similares

A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale
por: Shi, Xiaoping, et al.
Publicado: (2022)

Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic
por: Li, Xiaoye, et al.
Publicado: (2020)

Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
por: Yang, Hongyi, et al.
Publicado: (2019)

RUCAM in Drug and Herb Induced Liver Injury: The Update
por: Danan, Gaby, et al.
Publicado: (2015)

Curcuma longa Hepatotoxicity: A Baseless Accusation. Cases Assessed for Causality Using RUCAM Method
por: Stati, Gianmarco, et al.
Publicado: (2021)

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China
por: Leng, Bing, et al.
Publicado: (2022)

Vancomycin Associated Acute Kidney Injury: A Longitudinal Study in China
por: Kunming, Pan, et al.
Publicado: (2021)

Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM
por: Plüß, Marlene, et al.
Publicado: (2022)

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
por: Teschke, Rolf
Publicado: (2019)

Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM
por: Kobayashi, Takashi, et al.
Publicado: (2023)

Homocysteine Impairs Endothelial Cell Barrier Function and Angiogenic Potential via the Progranulin/EphA2 Pathway
por: Tian, Dan, et al.
Publicado: (2021)

Vancomycin associated acute kidney injury in patients with infectious endocarditis: a large retrospective cohort study
por: Kunming, Pan, et al.
Publicado: (2023)

Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients
por: Sun, Li-Hua, et al.
Publicado: (2022)

Population pharmacokinetics of tigecycline in critically ill patients
por: Luo, Xiangru, et al.
Publicado: (2023)

Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China
por: Chen, Yongwu, et al.
Publicado: (2021)

Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study
por: Li, Xiaoye, et al.
Publicado: (2021)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023)

Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China
por: Huang, Kaituo, et al.
Publicado: (2023)

Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause
por: Bokan, Goran, et al.
Publicado: (2023)

Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM
por: Andújar-Vera, Francisco, et al.
Publicado: (2023)

Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study
por: Li, Xiaoye, et al.
Publicado: (2022)

Platelet Function and Risk of Bleeding in Patients With Acute Coronary Syndrome Following Tirofiban Infusion
por: Li, Xiaoye, et al.
Publicado: (2019)

Impact of Renal Function on Effectiveness and Safety Associated With Low Dose Dabigatran in Non-valve Atrial Fibrillation Patients After Catheter Ablation
por: Li, Xiaoye, et al.
Publicado: (2021)

Acute Liver Failure following a Single Dose of Atezolizumab, as Assessed for Causality Using the Updated RUCAM
por: Tzadok, Roie, et al.
Publicado: (2022)

A Case of Delayed Hepatic Injury Associated with Teriflunomide Use as Assessed for Causality Using the Updated RUCAM
por: Wurzburger, Riana
Publicado: (2022)

The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties
por: Xu, Zhijie, et al.
Publicado: (2016)

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018)

Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature
por: Xia, Caixia, et al.
Publicado: (2020)

Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study
por: Cheng, Wei, et al.
Publicado: (2021)

Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis
por: Chen, Can, et al.
Publicado: (2021)

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
por: Zheng, Zhuangzhuang, et al.
Publicado: (2022)

Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment
por: Huan, Jia-Ming, et al.
Publicado: (2023)

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
por: Gotfried, Mark H., et al.
Publicado: (2017)

Study on plasma metabolomics for HIV/AIDS patients treated by HAART based on LC/MS-MS
por: Lao, Donghui, et al.
Publicado: (2022)

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
por: Lei, Yanna, et al.
Publicado: (2022)

PD-1 inhibitor-based adverse events in solid tumors: A retrospective real-world study
por: Huang, Guili, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data
por: Zhao, Jie, et al.
Publicado: (2022)

Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China
por: Tang, Wenjiao, et al.
Publicado: (2023)

Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM
por: Qin, Fu-Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rbkct4nvg6ju2livgs78oinj7o